Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

Brentuximab vedotin as a bridge to combination chemotherapy in gray zone lymphoma with severe liver impairment: a case report

BackgroundGray zone lymphoma (GZL) is a rare lymphoma subtype characterized by features intermediate between diffuse large B-cell lymphoma (DLBCL) and classic Hodgkin lymphoma (cHL). The optimal first-line treatment for GZL remains undefined, particularly for patients with poor performance status or...

Full description

Bibliographic Details
Main Authors: Roshan Asrani, Turgot Bora Cengiz, Bruce E. Petersen, Theodora Anagnostou, Joshua D. Brody
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
CD30+ lymphoma
targeted therapy
hyperbilirubinemia
Mdm4
IKBKE
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1254256/full

Similar Items

Similar Items